Skip to main content
logo
Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
1.575
+0.050 (3.28%)
At close: Nov 10, 2026, 4:00 PM EST
1.570
-0.005 (-0.32%)
After-hours: Nov 10, 2026, 7:30 PM EST

Cellyan Biotechnology Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Revenue
13.4313.4320.3116.6912.56
Revenue Growth
-17.89%-33.87%21.72%32.91%-
Gross Profit
1.391.392.423.562.74
Operating Income
-1-10.191.670.98
Net Income
-1.14-1.14-0.031.331
Earnings Per Share
-1.39-1.39-0.063.602.92
EPS Growth
---23.40%-

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash & Investments
0.220.223.010.620.52
Total Debt
1.261.262.372.090.69
Net Cash (Debt)
-1.04-1.040.63-1.47-0.17
Net Cash Growth
-----
Net Cash Per Share
-1.27-1.271.24-3.98-0.49

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Operating Cash Flow
-0.75-0.750.57-0.391.73
Capital Expenditures
-0.04-0.04-0.07-0.05-0.11
Free Cash Flow
-0.79-0.790.5-0.451.61
Free Cash Flow Growth
-----

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Gross Margin
10.32%10.32%11.89%21.32%21.81%
Operating Margin
-7.48%-7.48%0.94%10.00%7.80%
Pretax Margin
-8.40%-8.40%0.18%9.14%8.13%
Profit Margin
-8.46%-8.46%-0.13%7.97%7.95%
FCF Margin
-5.86%-5.86%2.46%-2.68%12.84%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23
P/FCF Ratio
--23.79--
PS Ratio
0.141.000.59--